key: cord-1040228-bpo69yzv
authors: Al Sheikh Ali, Adeeb; Khan, Daoud; Naqvi, Arshi; Al-blewi, Fawzia Faleh; Rezki, Nadjet; Aouad, Mohamed Reda; Hagar, Mohamed
title: Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives
date: 2020-12-31
journal: ACS Omega
DOI: 10.1021/acsomega.0c04595
sha: 47aeed8bb59cae06fb2aff6b2fb77dd9698df72c
doc_id: 1040228
cord_uid: bpo69yzv

[Image: see text] New conjugates of substituted 1,2,3-triazoles linked to 1,2,4-triazoles were synthesized starting from the appropriate S-propargylated 1,2,4-triazoles 7 and 8. Ligation of 1,2,4-triazoles to the 1,2,3-triazole core was performed through Cu(I)-catalyzed cycloaddition of 1,2,4-triazole-based alkyne side chain 7 and/or 8 with several un/functionalized alkyl- and/or aryl-substituted azides 9–15 to afford the desired 1,4-disubstituted 1,2,3-triazoles 16–27, using both classical and microwave methods. After their spectroscopic characterization (infrared, (1)H, (13)C nuclear magnetic resonance, and elemental analyses), an anticancer screening was carried out against some cancer cell lines including human colon carcinoma (Caco-2 and HCT116), human cervical carcinoma (HeLa), and human breast adenocarcinoma (MCF-7). The outcomes of this exploration revealed that compounds 17, 22, and 25 had a significant anticancer activity against MCF-7 and Caco-2 cancer cell lines with IC(50) values of 0.31 and 4.98 μM, respectively, in relation to the standard reference drug, doxorubicin. Enzyme-docking examination was executed onto cyclin-dependent kinase 2; a promising aim for cancer medication. Synthesized compounds acquiring highest potency showcased superior interactions with the active site residue of the target protein and exhibited minimum binding energy. Finally, the density functional theory (DFT) calculations were carried out to confirm the outcomes of the molecular docking and the experimental findings. The chemical reactivity descriptors such as softness (δ), global hardness (η), electronegativity (χ), and electrophilicity were calculated from the levels of the predicted frontier molecular orbitals and their energy gap. The DFT results and the molecular docking calculation results explained the activity of the most expectedly active compounds 17, 22, and 25.

Recently, the development of new chemotherapeutic (anticancer) candidates has been attracting the attention of researchers in life science-oriented research. 1 Among these, 1,2,3-triazole motifs were widely explored in medicinal chemistry and still their use is unavoidable because of their unique features such as strong dipole moments, hydrogen bond formation, dipole−dipole and π stacking interactions, and solubility. 2 As per the literature, 1,4-disubstituted 1,2,3triazoles were well known as crucial linkers and displayed bioisosteric effects. 2 These effects are probably because of their similarity to amide bonds in terms of planarity and distance. 3−6 Thus, 1,2,3-triazole cores were found in several drug structures and bioactive scaffolds showing anti-HIV, 7 antimicrobial, 8 antiviral, 9 and anticancer 10−15 activities.

Along with this, 1,2,4-triazole cores among the various heterocycles displayed a wide spectrum of biological properties, and are well documented in the literature. 16 This class also serves as antiviral, 17 antibacterial, 18 antifungal, 19 anti-inflammatory, 20 and anticancer 21 agents. The triazole skeletal moiety is an elite building block in the discovery of potent anticancer agents, and some of its analogues have already been made up to healthcare and clinics or are under clinical trials for fighting against various cancers. Hybrid compounds have captured an important position in cancer therapy, and hybridization of triazole scaffolds with other anticancer pharmacophores may furnish valuable therapeutic intervention for the cancer treatment (Figure 1 ), specifically drug-resistant cancer. 22 −25 On the other hand, physicochemical, pharmacokinetic, and pharmacodynamic properties have emerged as some of the crucial properties to appraise the effects or risks of drug candidates on human body. High-rate drug withdrawals escalate the pressure on the pharmaceutical industry and regulators to improve preclinical safety trials. Because in vitro and in vivo screenings are costly and laborious, in silico approaches have been widely implemented to estimate these traits. Computational tools play a pivotal role in drug-discovery programs, right starting from identification of hits to the optimization of the lead compounds and so on. Diverse computational methods and techniques are approachable, which aid in sieving the candidate drug from other molecules on the basis of various properties viz. drug likeness, physicochemical, pharmacodynamic, and pharmacokinetic traits. Molecular docking is a computational method, which is extremely useful and reasonably attested for forecasting putative affinities and binding modes of ligands with macromolecules. Furthermore, the speed and accuracy of the molecular docking approaches have been enhanced and these methods now play a noteworthy role in structure-based drug design. The newly synthesized hybrids were gauged using in silico docking studies for acquiring an additional apprehension of the binding pattern of the target ligands with the cyclindependent kinase 2 (CDK2), whose overexpression causes dysfunction of the cell cycle, which is thoroughly allied with hyperproliferation of cancer cells. 26−29 Numerous evidences have been put forward in the literature sustaining the concept of restraining cancer progression by aiming CDK2. 30 2. RESULTS AND DISCUSSION 2.1. Chemistry. The synthetic strategies adopted in the present work are depicted in Schemes 1 and 2. The targeted 1,2,4-triazole-1,2,3-triazole molecular conjugates 16−27 were synthesized from two 1,2,4-triazole units 5 and 6 as starting materials (Scheme 2), which in turn were obtained through mulistep synthesis from the appropriate acid hydrazides, 1 and 2, according to the reported procedures 55,56 (Scheme 1). Thermal condensation of benzohydrazide (1) and acetohydrazide (2) with phenylisothiocyanate for 4 h gave the respective acid thiosemicarbazides 3 and 4 in 86 and 85% yields; MWI required 2 min to give 96 and 95% yield of 3 and 4, respectively.

MWI of a solution of acid thiosemicarbazide 3 and/or 4 in aqueous sodium hydroxide for 3 min resulted in the formation of the targeted precursors namely 4-methyl-5-phenyl-4H-1,2,4triazole-3-thione (5) and 4,5-diphenyl-4H-1,2,4-triazole-3thione (6) in 93 and 92% yields, respectively (Table 1) .

1,2,4-Triazoles 5 and 6 were conventionally obtained in 84− 85% yields, by thermal dehydrative intramolecular cyclization of the corresponding thiosemicarbazide derivatives 3 and/or 4 in aqueous sodium hydroxide for 4 h, as reported in the literature.

The success of the intramolecular cyclodehydration was also supported by the spectral data of the resulted 1,2,4-triazoles 5 and 6. Their infrared (IR) spectra exhibited common characteristic absorption bands at 3276−3389 cm −1 assigned to (NH), 1288−1295 cm −1 (CS), and 1620−1625 cm −1 (CN) confirming the formation of the triazole ring. In their 1 H nuclear magnetic resonance (NMR) spectra, the appearance of the diagnostic triazole-NH singlet at δ H 13.70−14.16 ppm was a clear proof for the formation of the targeted triazoles 5 and 6 in their thione forms. In addition, the signal belonging to the CS group was recorded at δ C 167.34− 168.57 ppm confirming the predominance of the thione isomer. All these spectral data supported that compounds 3 and 4 underwent ring closure to give the corresponding 1,2,4triazoles 5 and 6, respectively. The 1,3-dipolar cycloaddition reaction of organoazides with terminal alkynes was reported as an efficient and convenient method for the regioselective synthesis of 1,4-disubstituted 1,2,3-triazoles. 57 This strategy is right way a center of attention because of its high regioselectivity that runs into the demand of click chemistry in organic synthesis. 57 Accordingly, the synthesis of the targeted 1,2,3-triazoles with thio-1,2,4-triazole connected via a flexible methylene spacer involved Huisgen 1,3-dipolar cycloaddition of the thiopropargylated 1,2,4triazoles 7 and/or 8 as terminal alkynes with different un/ functionalized alkyl-and/or aryl-substituted azides 9−15 (Scheme 2). Therefore, the alkyne precursors 7 and 8 were successfully synthesized in 91−92% yields through the propargylation of the 1,2,4-triazole-3-thiones 5 and 6 in the presence of triethylamine as basic catalyst for 1 h. Under MWI, only 2 min was required to give the same thiopropargylated-1,2,4triazoles 7 and 8 in excellent yield (97−98%) ( Table 1 ). The structures of the thiopropargylated derivatives 7 and 8 were elucidated based on their spectral data. Their IR spectra exhibited their principal functional groups. The acetylenic hydrogen (C−H) and carbons (−CC−) were recorded at 3305−3328 and 2145−2155 cm −1 , respectively.

The investigation of their 1 H NMR spectra revealed the presence of a diagnostic triplet and a doublet in the aliphatic region at δ H 2.24−3.28 and 3.94−4.00 ppm relative to sp-CH and SCH 2 protons, respectively, confirming the incorporation of the propargyl side chain. In addition, their 13 C NMR spectra confirmed the propargyl carbon signals (SCH 2 and CC) resonating around δ C 20.89−21.27 and 72.34−79.48 ppm, respectively. The remaining carbons were also recorded on their respected chemical shifts (see the Experimental Section).

The targeted 1,2,4-triazole-1,2,3-triazole molecular conjugates 16−27 were well synthesized via the Cu(I)-assisted 1,3dipolar cycloaddition of the latest thiopropargylated 1,2,4triazoles 7 and 8 with some selected azides 9−15 at room temperature for 8−10 h in the presence of copper sulfate and sodium ascorbate as catalysts. It was noticeable that the 1,2,3triazoles carrying aliphatic side chain (benzyl, alkyl long chain and/or ester side chain) at N-1 atom 16−21 were obtained in good yields (86−88%) compared to their analogues bearing aromatic substituents 22−27 (81−83%). On the other hand, it was observed that the click ligation has been successfully accomplished under MWI and afforded the desired click products 16−27 in excellent yields (90−96%) with a great reduction in reaction times (4−6 min) ( Table 1 ). It should be noted that the used azides 9−15 were synthesized from their respective alkyl halides and/or substituted anilines as reported in the literature. 58−60 The structures of the 1,2,3-triazoles 16−27 have been established on the basis of their spectral data (IR, 1 H NMR, 13 C NMR, and elemental analysis). All the IR spectra showed clearly the disappearance of the alkyne groups (CC) and sp-H of their starting materials, confirming their involvement in the cycloaddition reaction.

Almost all the synthesized click adducts 16−27 displayed similar spectral patterns ( 1 H NMR and 13 C NMR). Their 1 HNMR spectra confirmed the absence of the signals related to the lateral hydrogen of the C−H group of their corresponding alkynes 7 and 8 around δ H 2.24−2.28 ppm, and showed the presence of one distinct signal at δ H 8.01−8.85 ppm attributed to the 1,2,3-triazole-CH proton supporting the formation of such a ring. The 1,2,3-triazole derivatives 16−21 exhibited the common NCH 2 protons at 4.30−5.57 ppm. In addition, the 1 H and 13 C NMR spectra of compounds 16−19 were characterized by the appearance of extra aromatic protons and carbons. Moreover, a triplet and a quartet were observed at 1.21−1.22 and 4.15−4.18 ppm in the 1 H NMR spectra attributed to the ethyl group of the ester functionality appended by the triazoles 20 and 21. Additionally, in their 13 C NMR spectra, their structure was also evidenced by the appearance of the carbonyl ester carbon around 166.99− 167.81 ppm. In contrast, the triazoles 22−27 appended with aromatic rings revealed the presence of three or four extra protons and carbons in their 1 H and 13 C NMR spectra (see the Experimental Section).

2.2. DFT Molecular Structure Estimation. The theoretical calculations by the DFT were done in the gas phase at the B3LYP 6-311G(d,p) basis set implemented into the Gaussian 9. This included the simulation of the geometrical optimization on each prepared compound to determine the minimum energy molecular structure, followed by the calculation of the frequency at the optimized structural geometry during which many thermochemical quantities are also calculated. All optimum structures of the prepared compounds (7, 8, and 16−27) are considered stable because of the absence of the imaginary frequency. The findings of the DFT of the optimized molecular structures for all investigated compounds show the nonplanarity of all compounds as shown in Figure 2 .

2.3. In Vitro Anticancer Screening. The synthesized compounds, 7, 8, and 16−27 were in vitro screened for anticancer activity using four different cancer cell lines namely human colon carcinoma (Caco-2 and HCT116), human cervical carcinoma (HeLa), and human breast adenocarcinoma (MCF-7). The standard reference drug considered was doxorubicin. The data are summarized in Table 2 In order to qualify to be a drug candidate, some prerequisites such as physicochemical, pharmacodynamic, and pharmacokinetic parameters should be attained by any chemical entity. Thus, the potential of a drug aspirant can be evaluated by forecasting in silico physicochemical attributes, drug likeness, or adsorption, distribution, metabolism, excretion, and toxicity (ADMET) traits. In silico analysis was performed to corroborate the reliability of in vitro anticancer screenings. Calculations were made for different physicochemical characteristics such as the enumeration of particular atom class, the count of rotatable bonds, lipophilicity, molar refractivity, and water solubility. Topological polar surface area (TPSA), an attribute that is explored to forecast the passive molecular transport trait of drugs, was also appraised. These physicochemical properties are shown in Table 3 . The physicochemical attributes are in good agreement with the applied criteria and are expected to have good bioavailability score as all the compounds have TPSA ≤ 140 Å.

In silico pharmacokinetic/ADME evaluations were executed, and the forecasted data are presented in Table 4 , which unveil that all the screened compounds showed high gastrointestinal 

http://pubs.acs.org/journal/acsodf Article absorptions (GI) except compound 17. All of them have no BBB (blood brain barrier) permeability except compounds 7 and 8. The majority of the compounds are P-gp (pglycoprotein) noninhibitors. The prediction for BBB permeations, passive human GI absorption, and P-gp substrates is pooled in a built-in graphical classification model, that is, the BOILED-Egg diagram, as displayed in Figure 3 . All the synthesized compounds were tested for inhibition of the Cytochrome P450 isomers, that is, CYP1A2, CYP2C19, CYP2C9, CYP2D6, and CYP3A4. Most of the compounds are CYP1A2 inhibitors except 16 and 21−24. All the tested compounds are inhibitors of CYP2C19 with the exception of compound 17 for CYP2C9 and compounds 7 and 8 for CYP3A4. The tested compounds emerged to be noninhibitors of CYP2D6. The tested compounds possess low skin permeability.

In silico AMES toxicity and carcinogenicity are assessed and are given in Table 5 . All the synthesized compounds were noncarcinogenic and AMES nontoxic in nature except compounds 7, 8, 16, and 19, which emerged to be AMES toxic in nature. Furthermore, the computed rat acute toxicity, that is, LD 50 in mol/kg seems to be sufficiently safe in the range 2.238−2.74 mol/kg. The FMO and the highest occupied (HOMO) and lowest unoccupied (LUMO) molecular orbitals have been in focus for clarifying several forms in chemical reactivity. Recently, the impact of the FMOs of the materials on their biological reactivity have been taken into consideration. Many reports 61, 62 show the correlation between FMOs and several biological properties such as antimicrobial, 63−65 anticancer, 66−68 antifungal, 69, 70 and cytotoxic 71−73 activities, which is a new drug-design field. 74 The energy level as well as the energy gap of the FMOs (E HOMO , E LUMO and ΔE) are good tools to explore several important parameters such as the potential required for ionization from the HOMO level (I = −E HOMO ) and the electron affinity from the energy of the LUMO (A = −E LUMO ). In addition, the FMOs are excellent in appraising various chemical reactivity descriptors such as softness (δ), global hardness (η), electronegativity (χ), and electrophilicity (ω). These parameters are calculated according to the following equations 75

The χ value is an appraisal for the behavior of the compound to accept electrons, that is, Lewis acidity ( Table 6 ). The magnitude of the molecules for charge transfer prevention is calculated from the global hardness (η); however, the global softness (δ) describes the capability of a molecule for electronic transportation. 75 Soft compounds have a small FMO energy gap and are more reactive to transfer their electrons to the acceptors than the harder one.

The electrophilicity (ω) could be calculated from the predicted electronegativity and chemical hardness is an indicator for the lower energy because of the highest electronic gap between the acceptor LUMO and the donor HOMO.

The binding affinity in kcal/mol of all the docked ligands is given in Table 7 . The ligands unveiled good to excellent binding affinities toward the target receptor CDK2 ranging from −9.9 to −6.9 kcal/mol. The molecular docking studies disclosed that the compounds 17, 22, and 25 were the most promising candidates, which is justified by lowest binding energy, that is, −9.4, −9.9. and −9.1 kcal/mol, respectively, with the CDK2 active site residues. Docking and 2D diagrams illustrating protein−ligand interactions of these compounds, that is, 17, 22, and 25, are shown in Figure 4a ,b, respectively. These compounds entrenched a network of interactions at the molecular level, that is, H-bonds, atomic charge, and π−σ interactions with the CDK2 active site residues when examined in 2D plots. Distinct interactions were depicted by different colors: for example, purple indicates the covalent bond; pink denotes electrostatic interaction; and green indicates van der Waals molecular interaction. Light blue shading surrounding the atom or residue reveals the solvent accessibility of the ligand atom and the amino acid residues while high shading signifies more exposure to solvent. Compound 77 Veber, 78 Egan, 79 and Muegge 80 rules were implemented. Moreover, the bioavailability scores along with the number of violations to these rules are given in Table 7 .

Our results regarding the drug-like attributes showed that most of our compounds obeyed these rules with few exceptions. The entire tested compounds were in good agreement in terms of the bioavailability score being 0.17−0.55. In sequence of analyzing the binding affinity of the ligands with the target protein, molecular docking studies of newly synthesized target compounds on CDK2 (PDB ID: 2R3I) as the target receptor Table 7) . All of these investigated factors show a range of significant influences on the affinity for their binding with active protein sites as shown in Figure 5 .

2.5. Molecular Electrostatic Potential. To confirm the evidence for the interaction of these compounds as inhibitors, the molecular electrostatic potential (MEP) could be a significant trait to be calculated. Although the MEP shows information about the shape and the size of the electrostatic potential, it can also be a tool for predicting physiochemical property relationships with the molecular structure. Moreover, MEP is a useful tool for predicting the effectiveness of the studied compounds toward electrophilic and nucleophilic attacks.

The MEP of the best binding affinity compounds 17, 22, and 25 is estimated using the same method and basis sets and is given in Figure 6 . It is evident that the size and shape as well 

http://pubs.acs.org/journal/acsodf Article as the orientation of the negative (red, electrophilic attack sites), positive (blue, nucleophilic attack sites), and neutral potentials differ according to the electronic nature of the attached groups. The difference in mapping this electrostatic potential around the drug-like compounds is mainly responsible for the degree to which the binding to the receptors occurs at the active sites of the targeted receptor.

A focused library of 1,2,3-triazoles encompassing 1,2,4-triazole cores was designed and successfully synthesized through a click reaction of a proper S-propargylated 1,2,4-triazoles 7 and 

All reagents and solvents used were of the highest quality of analytical reagent grade and were used without further purification. Fine chemicals and solvents were purchased from BDH Chemicals Ltd. and Sigma-Aldrich. Melting points are uncorrected and were measured on a Stuart Scientific SMP. Thin layer chromatography (TLC) was performed on UV fluorescent Silica gel Merck 60 F254 plates, and the spots were visualized using a UV lamp (254 nm). FT-IR spectrometer type PerkinElmer 1430 series was used for the investigation of the functional groups in the range of 400−4000 cm −1 . The NMR spectra were obtained using a Bruker spectrometer (400 MHz) with tetramethylsilane as an internal reference. Elemental analyses were performed using a GmbH-Vario EL III Elementar Analyzer. 4.1. General Procedure for the Synthesis of Acid Thiosemicarbazides 3−4. 4.1.1. Conventional Procedure. Benzohydrazide (1) and/or acetohydrazide (2) (10 mmol) was dissolved in ethanol (30 mL) containing phenylisothiocyanate (10 mmol). The mixture was heated under reflux for 4 h, and the reaction was monitored by TLC. After cooling, the crude product was collected by filtration and recrystallized from ethanol to afford the targeted acid thiosemicarbazides 3−4.

4.1.2. Microwave Procedure. In a closed borosilicate glass vessel fitted with a silicone cap, a solution of 3-benzohydrazide (1) and/or acetohydrazide (2) (1 mmol) dissolved in ethanol (5 mL) containing phenylisothiocyanate (1 mmol) was exposed to irradiation for 2 min using a microwave reactor. The reaction was processed as described in the conventional procedure (CP) outlined earlier to afford the same acid thiosemicarbazides 3−4. The appropriate acid thiosemicarbazide 3−4 (10 mmol) was dissolved in 10% aqueous solution of sodium hydroxide (100 mL). The mixture was allowed to react at reflux for 4 h, cooled, filtered, and acidified with hydrochloric acid. The crude product was collected by filtration and recrystallized from ethanol to afford the targeted 1,2,4-triazoles 5−6.

4.2.2. Microwave Procedure. In a closed borosilicate glass vessel fitted with a silicone cap, a solution of the appropriate acid thiosemicarbazide 3−4 (1 mmol) dissolved in 10% aqueous solution of sodium hydroxide (10 mL) was exposed to irradiation for 3 min using a microwave reactor. The reaction was processed as described in the CP outlined earlier to afford the same 1,2,4-triazoles 5−6. In a closed borosilicate glass vessel fitted with a silicone cap, a solution of the appropriate triazoles 5−6 (1 mmol) dissolved in ethanol (5 mL) containing triethylamine (1 mmol) and propargyl bromide (1.2 mmol) was exposed to irradiation for 2 min using a microwave reactor. The reaction was processed as described in the CP outlined earlier to afford the same thiopropargylated-1,2,4-triazoles 7−8. 15 g) , and the appropriate azide 9−15 (1 mmol) was exposed to irradiation for 4−6 min using a microwave reactor. The reaction was processed as described in the CP outlined earlier to afford the same 1,2,3-triazoles 16−27. The cytotoxic activity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay as reported previously. 84−86 In brief, the tumor cell lines were suspended in a medium at a concentration of 1 × 104 cell/well in Corning 96-well tissue culture plates and then incubated for 24 h. The tested compounds with concentrations were then added into 96-well plates to achieve different conc. for each compound. After incubating for 24 h, the numbers of viable cells were determined using the MTT test. Briefly, the medium was removed and the MTT solution (50 μL, 0.5 mg/mL in RPMI 1640 without phenol red) was added. After 3 h of incubation, the MTT solution was removed and the acquired formazan was dissolved in the isopropanol/HCl system. The 96-well plates were then incubated at 37°C and 5% CO 2 for 4 h. Finally, the optical density was measured at 570 nm with the microplate reader to determine the number of viable cells and the percentage of viability was calculated as [1 − (ODt/ODc)] × 100% where ODt is the mean optical density of wells treated with the tested sample and ODc is the mean optical density of untreated cells. The experiment was conducted in three independent iterations with four technical repetitions. Tests were conducted at concentrations ranging from 0.01 to 0.8 mM. The 50% inhibitory concentration (IC 50 ), the concentration required to cause toxic effects in 50% of intact cells, was estimated from graphic plots of the dose−response curve for each concentration using CalcuSyn.

4.6. In Silico Analysis. Various physicochemical, pharmacokinetic, and pharmacodynamic traits (i.e., fragment-based drug likeness and violations, clog P, TPSA, ADMET, and so forth) of the synthesized compounds were forecasted employing various computational tools.

4.6.1. Molecular Docking Studies. The 3D atomic coordinates of the tested compounds were modeled using the Marvin sketch software (https://chemaxon.com/products/ marvin). These target ligands were further optimized and energy minimized utilizing the Dundee PRODRG2 server. 87 These energy optimized compounds were availed to execute the molecular docking studies. The 3D crystallographic ACS Omega http://pubs.acs.org/journal/acsodf Article structure of the molecular aspirant was acquired from Protein Data Bank (PDB) (www.rcsb.org): CDK-2 (PDB: 2R3I). The receptor was prepared by the removal of heteroatoms (water and ions). The active site of the target receptor was predicted by utilizing the BIOVIA Discovery studio visualizer. 88 The ligands were docked into the predicted active site of the CDK2, in order to interpret their binding interaction in silico and to analyze their anticancer activity. The docking study was carried out by PyRx software using AutoDock vina as the engine for docking, which is based on the scoring function. 89 Grid resolutions were utilized to perform docking simulations. The grid was defined as a spherical region that encloses all the active site residue within 15.0 Å of the confined crystallographic ligand atom. At every step of the docking simulation, the binding energy of the interaction between the ligand and protein was gauged by exercising atomic affinity potentials computed on a grid. All the calculations were conducted exploiting the default settings. For 2D and 3D visualizations, the BIOVIA Discovery studio visualizer was employed.

triazol-3-yl)thio)methyl)-1-hexadecyl-1H-1

DMSO-d 6 ): δ H 0.86 (3H, t, J = 6.0 Hz, CH 3 ), 1.21−1.26 (28H, m, 14× CH 2 ), 4.30 (2H, t, J = 6.0 Hz

5-Diphenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1-hexyl-1H-1

1630 cm −1 (CN). 1 H NMR (400 MHz

CH 3 ); 21.79, 25.34, 26.68, 29.51 (4× CH 2 ); 30.44 (SCH 2 )

Characterization of 1-Benzyl-4-(((5-methyl-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1

DMSO-d 6 ): δ H 2.18 (3H, s, CH 3 ), 4.35 (2H, s, SCH 2 ), 5.56 (2H, s, NCH 2

5-Diphenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)acetate (20)

DMSO-d 6 ): δ H 1.21 (3H, t, J = 6.0 Hz

Methyl-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)-acetate (21)

1742 (CO), 1628 cm −1 (CN). 1 HNMR

CH 3 CH 2 O)

CH 3 CH 2 O)

Characterization of 1-(4-Bromophenyl)-4-(((4,5-diphenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1

1630 cm −1 (CN). 1 H NMR (400 MHz, DMSOd 6 ): δ H 4.55 (2H, s, SCH 2 ), 7.35−7.40 (7H, m, H Ar ), 7.53− 7.55 (3H, m, H Ar ), 7.80−7.87 (4H, m, H Ar ), 8.76 (1H, s, CH-1,2,3-triazole). 13 C NMR (100 MHz

5-Diphenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1-(4-fluorophenyl)-1H-1

92 (2H, br s, H Ar ), 8.74 (1H, s, CH-1,2,3-triazole). 13 C NMR (100 MHz, DMSO-d 6 ): δ C 26

Found: C, 64.67

5-diphenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1

CH-Al), 1632 cm −1 (CN). 1 H NMR (600 MHz

97 (1H, dd, J = 6.0 Hz, 12.0 Hz, H Ar ), 8.26 (1H, d, J = 6.0 Hz, H Ar ), 8.85 (1H, s, CH-1,2,3-triazole). 13 C NMR (150 MHz, DMSO-d 6 ): δ C 27

Characterization of 1-(4-Bromophenyl)-4-(((5-methyl-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1

1630 cm −1 (CN). 1 H NMR (400 MHz, DMSO-d 6 ): δ H 2.20 (3H, s, CH 3 ), 4.43 (2H, s, SCH 2 ), 7.40− 7.43 (2H, m, H Ar ), 7.55−7.58 (3H, m, H Ar

Characterization of 1-(4-Fluorophenyl)-4-(((5-methyl-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1

DMSO-d 6 ): δ H 2.20 (3H, s, CH 3 ), 4.45 (2H, s, SCH 2

Calcd for C 18 H 15 FN 6 S: C

methyl-4-phenyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1H-1

1622 cm −1 (CN). 1 H NMR (600 MHz, DMSO-d 6 ): δ H 2.11 (3H, s, CH 3 ), 4.44 (2H, s, SCH 2

CH 3 )

Anticancer Activity. 4.5.1. Cell Lines. The human colorectal adenocarcinoma cell line (Caco-2), the human colorectal carcinoma cell line (HCT-116), the human uterine cervical cancer cell line (HeLa), and the human breast adenocarcinoma cell line (MCF-7)

The role of the medicinal chemist in drug discovery -then and now

The 1,2,3-triazole ring as a bioisostere in medicinal chemistry

Click chemistry in peptide-based drug design

Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions

Chemistry: 1,2,3-Triazoles as Pharmacophores

Click chemistry finds its way into covalent porous organic materials

Identification of 1-aryl-1H-1, 2, 3-triazoles as potential new antiretroviral agents

Synthesis, and Antimicrobial Activities of 1,2,3-Triazole Glycoside Clickamers

Synthesis and antiviral activity of 1,2,3-triazole glycosides based substituted pyridine via click cycloaddition

3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships

Cuevas-Yanẽz, E. Synthesis, characterization and cytotoxic activity evaluation of 4-(1,2,3-triazol-1-yl) salicylic acid derivatives

1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line

Discovery of a Novel Benzenesulfonamide Analogue That Inhibits Proliferation and Metastasis Against Ovarian Cancer OVCAR-8 Cells

Molecular mechanism of action of new 1, 4-naphthoquinones tethered to 1, 2, 3-1H-triazoles with cytotoxic and selective effect against oral squamous cell carcinoma

3-triazoyl carboxamides induce cell cycle arrest and apoptosis in human bladder carcinoma cells

1,2,4-Triazoles: A Review of Synthetic Approaches and the Biological Activity

New vinyl-1,2,4-triazole derivatives as antimicrobial agents: Synthesis, biological evaluation and molecular docking studies

Synthesis, antifungal and antibacterial activity of novel 1,2,4-triazole derivatives

Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies

Balan-Porcarasu, M. Design, synthesis and biological activity evaluation of Ssubstituted 1H-5-mercapto-1,2,4-triazole derivatives as antiproliferative agents in colorectal cancer

A novel triazole derivative drug presenting in vitro and in vivo anticancer properties

Biological Properties of 1H-1, 2, 3-and 2H-1, 2, 3-Triazoles

Cyclindependent kinase 2 inhibitors in cancer therapy: An update

Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15

cyclins and CKIs: roles beyond cell cycle regulation

CDKs and cancer: a changing paradigm

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents

Cyclin B and cyclin A confer different substrate recognition properties on CDK2

Oxindole-based inhibitors of cyclindependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis

Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer

SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells

Circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene

New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies

Synthesis, biological assessment, and structure activity relationship studies of new flavanones embodying chromene moieties

Specific Overexpression of Cyclin E·CDK2 in Early Preinvasive and Primary Breast Tumors in Female ACI Rats Induced by Estrogen

Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity

Regioselective synthesis and evaluation of novel sulfonamide 1,2,3-triazole derivatives as antitumor agents

Synthesis and Anticancer Activity of New Thiazole-Tetrazole or Triazole Hybrid Glycosides Targeting CDK-2 via Structure-Based Virtual Screening

MCR-click synthesis, molecular docking and cytotoxicity evaluation of a new series of indole-triazolecoumarin hybrid peptidomimetics

Design, synthesis, in silico and in vitro antimicrobial screenings of novel 1,2,4-triazoles carrying 1,2,3-triazole scaffold with lipophilic side chain tether

Design, synthesis, in-silico and in-vitro evaluation of di-cationic pyridinium ionic liquids as potential anticancer scaffolds

Identification of new pyridinium ionic liquids tagged with Schiff bases: Design, synthesis, in silico ADMET predictions and biological evaluations

Novel amphiphilic pyridinium ionic liquids-supported Schiff bases: ultrasound assisted synthesis, molecular docking and anticancer evaluation

Hydrophobic pocket docking, double-proton prototropic tautomerism in contradiction to single-proton transfer in thione ⇔thiol Schiff base with triazole-thione moiety: Green synthesis, XRD and DFT-analysis

Design, click synthesis, anticancer screening and docking studies of novel benzothiazole-1,2,3-triazoles appended with some bioactive benzofused heterocycles

A Profile of the In Vitro Anti-Tumor Activity and In Silico ADME Predictions of Novel Benzothiazole Amide-Functionalized Imidazolium Ionic Liquids

DNA Binding, Anticancer, and Molecular Docking Studies of Novel ACS Omega

Imidazolium-Based Ionic Liquids with Fluorinated Phenylacetamide Tethers

Novel Fluorinated Imidazolium Ionic Liquids: Eco-friendly, Facile and Efficient Construction, Characterization, in vitro Anticancer Activity, Toxicity and in silico Analysis

Microwave and conventional synthesis of ester based dicationic pyridinium ionic liquids carrying hydrazone linkage: DNA binding, anticancer and docking studies

Synthesis of 5-Aryl-3-Glycosylthio-4-Pheny-4H-1, 2,4-Triazoles and Their Acyclic Analogs Under Conventional and Microwave Conditions

A One-Pot Synthesis of 4,5-Disubstituted-1,2,4-triazole-3-thiones on Solid Support under Microwave Irradiation. Phosphorus, Sulfur Silicon Relat

1,3-Dipolar cycloreversion of a 1,3,4-oxadiazolidine as a controlled azomethine imine surrogate for pyrazolidine synthesis

Indole-triazole conjugates are selective inhibitors and inducers of bacterial biofilms

Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores

Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors

Essential oils of different cultivars ofCannabis sativa L. and their antimicrobial activity

Medicinal chemistry of cannabinoids

Quantitative structure-property relationships in pharmaceutical research -Part 1

Synthesis, characterization, antimicrobial activities, and QSAR studies of organotin (IV) complexes. Phosphorus, Sulfur Silicon Relat

The Simulating Study of HOMO, LUMO, thermo physical and Quantitative Structure of Activity Relationship (QSAR) of Some Anticancer Active Ionic Liquids

New N-ribosides and N-mannosides of rhodanine derivatives with anticancer activity on leukemia cell line: Design, synthesis, DFT and molecular modelling studies

Structural, spectral, theoretical and anticancer studies on new co-crystal of the drug 5-fluorouracil

Mesophase behavior and DFT conformational analysis of new symmetrical diester chalcone liquid crystals

Synthesis, spectroscopic characterization, DFT studies and antifungal activity of (E)-4-amino-5-[N′-(2-nitro-benzylidene)-hydrazino]-2,4-dihydro

IV) complexes of Schiff base derived from 1,2,4-triazole moiety: Synthesis, spectroscopic investigation, DFT studies, antifungal activity and molecular docking studies

Comprehensive exploration of the anticancer activities of procaine and its binding with calf thymus DNA: a multi spectroscopic and molecular modelling study

Synthesis, DFT and POM analyses of cytotoxicity activity of αamidophosphonates derivatives: Identification of potential antiviral O,O-pharmacophore site

In vitro cytotoxicity and structure-activity relationship approaches of ent-kaurenoic acid derivatives against human breast carcinoma cell line

Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s

Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods

Molecular properties that influence the oral bioavailability of drug candidates

Prediction of intestinal permeability

Simple selection criteria for drug-like chemical matter

Role of Resultant Dipole Moment in Mechanical Dissociation of Biological Complexes

Molecular Recognition of Azelaic Acid and Related Molecules with DNA Polymerase I Investigated by Molecular Modeling Calculations

Physiochemical, molecular docking, and pharmacokinetic studies of Naproxen and its modified derivatives based on DFT

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Bioassay Techniques for Drug Development By Atta-ur-Rahman, M. Iqbal Choudhary

Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

Pharmacophore And Ligand-Based Design With Biovia Discovery Studio

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading